C4X Discovery Holdings PLC | Key People and Executives
Eva-Lotta Allan
Non-Executive Chairman
Clive James Dix
Chief Executive Officer & Executive Director
Bradley Richard Hoy
Chief Financial Officer & Director
Craig Fox
Chief Scientific Officer & Director
Natalie Louise Walter
Non-Executive Director
Alexander James Stevenson
Non-Executive Director
Harry Finch
Independent Non-Executive Director
Eva-Lotta Allan
Non-Executive Chairman
Clive James Dix
Chief Executive Officer & Executive Director
Bradley Richard Hoy
Chief Financial Officer & Director
Craig Fox
Chief Scientific Officer & Director
Bhavna Hunjan
Head-Strategy
Thorsten Nowak
Vice President-Structural Design
Natalie Louise Walter
Non-Executive Director
Alexander James Stevenson
Non-Executive Director
Mark James Sullivan
Secretary
Harry Finch
Independent Non-Executive Director
| Address |
Manchester One
Manchester Greater Manchester M1 3LD
United Kingdom
|
|
Employees
|
- |
| Website |
http://c4xdiscovery.com/ |
| Updated |
07/08/2019 |
| C4X Discovery Holdings Plc engages in the development of new technologies to improve the drug discovery process for novel small molecule therapies. Its software platforms consists of Taxonomy3, which utilizes a mathematical approach to discovery and validation of drug targets for the treatment of a variety of diseases; and Conformetrix, which determines the 3D shape of drug molecules from experimental in vitro data that enables the rapid design and discovery of novel and potent drugs for diseases with high unmet medical need across broad therapeutic areas. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. |
